About Dynein assembly factor with WD repeat domains 1
Dynein assembly factor with WD repeat domains 1 (DAW1) is a protein
from Homo sapiens identified by UniProt accession
Q8N136, 415 residues long.
MolForge cross-references it against 0 known binders and
75 disease associations.
Target properties
| Protein name | Dynein assembly factor with WD repeat domains 1 |
| UniProt accession | Q8N136 |
| Gene | DAW1 |
| Organism | Homo sapiens |
| Length | 415 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (75)
Diseases linked to this target (Open Targets).
- primary ciliary dyskinesia · score 0.50
- asthma · score 0.38
- allergic rhinitis · score 0.36
- Eczematoid dermatitis · score 0.36
- adolescent idiopathic scoliosis · score 0.26
- seasonal allergic rhinitis · score 0.25
- neurodegenerative disease · score 0.20
- ciliopathy · score 0.19
- allergic disease · score 0.12
- Heterotaxia · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8N136-F1 | alphafold | PREDICTED | 96.62 | — |
Amino-acid sequence (415 residues)
MKLKSLLLRY YPPGIMLEYE KHGELKTKSI DLLDLGPSTD VSALVEEIQK AEPLLTASRT EQVKLLIQRL QEKLGQNSNH TFYLFKVLKA HILPLTNVAL NKSGSCFITG SYDRTCKLWD TASGEELNTL EGHRNVVYAI AFNNPYGDKI ATGSFDKTCK LWSVETGKCY HTFRGHTAEI VCLSFNPQST LVATGSMDTT AKLWDIQNGE EVYTLRGHSA EIISLSFNTS GDRIITGSFD HTVVVWDADT GRKVNILIGH CAEISSASFN WDCSLILTGS MDKTCKLWDA TNGKCVATLT GHDDEILDSC FDYTGKLIAT ASADGTARIF SAATRKCIAK LEGHEGEISK ISFNPQGNHL LTGSSDKTAR IWDAQTGQCL QVLEGHTDEI FSCAFNYKGN IVITGSKDNT CRIWR
Explore Dynein assembly factor with WD repeat domains 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets